Industry Relations and Technology Transfer

Featured Breakthroughs

Technologies available from Fred Hutch

Highlight 1
Muscular Dystrophy (FSHD) Targets
The identification of genes and proteins that damage muscle cells and the mechanisms that cause facioscapulohumeral muscular dystrophy (FSHD), the third most common form of inherited muscular dystrophy, provides a foundation for development of first-in-class therapeutics and biomarker based diagnostic tests.
Learn more »
Highlight 2
New Class of Drug Leads
Fred Hutch scientists are developing a new class of drug scaffolds capable of targeting protein-protein interactions. These proprietary drug leads may act as targeting agents for specific imaging and therapeutic applications.
Learn more »
Highlight 3
Accurate, Sensitive and Targeted Sequencing Technologies
Several new sequencing technologies combine to provide a foundational platform for the detection and sequencing of rare mutations and rare cells with extraordinary sensitivity and accuracy.
Learn more »
Highlight 4
Improved Screening Platform and Cancer Therapeutic Targets
An efficient high-throughput screening platform for discovery and validation of potential cancer drug targets through oncogene synthetic lethal interactions in human foreskin fibroblasts (HFF). Identified several novel therapeutic targets for Myc driven and p53 mutant cancers.
Learn more »
Highlight 5
Cord Blood Transplant
Breakthrough advances in cord blood stem cell expansion, banking and therapeutic application provide the foundation for an off-the-shelf product to significantly improve cord blood transplantation.
Learn more »
Highlight 6
Broad Spectrum Anti-Bacterial Drugs
Proprietary drug leads that are potential first-in-class, broad-spectrum antibiotics inhibiting both DNA gyrase and RecBCD/AddAB DNA repair enzymes. The lead compounds may have the potential to treat difficult infectious diseases such as tuberculosis and are less likely to become ineffective due to drug resistance.
Learn more »
1 of 1 | Next »

For Inventors

Molecule model

Whether you have a new invention, want to partner with industry or start a business, we are here to help.

Learn More »

For Industry/Investors

Business people talking

Partner with us to access our innovations or collaborate with our faculty.

Learn More »

Available Technologies
Search our database of available technologies

 

Policies and Forms
Download copies of important Hutchinson Center documents

Core Services

  • Evaluate commercial potential of inventions
  • Protect and manage intellectual property
  • Identify opportunities and market ideas to industry
  • License intellectual property in a manner that encourages product development and generates a fair financial return for the Center
  • Negotiate and administer partnership agreements including material transfer, confidentiality, collaboration and sponsored research agreements
  • Facilitate clinical and non-clinical research partnerships with industry
  • Create new businesses based on Center technologies

  

Fred Hutchinson Cancer Research Center is a world leader in research to prevent, detect and treat cancer and other life-threatening diseases.